Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies

被引:33
|
作者
Leas, Eric C. [1 ]
Hendrickson, Erik M. [1 ,2 ]
Nobles, Alicia L. [1 ,3 ]
Todd, Rory [1 ]
Smith, Davey M. [3 ]
Dredze, Mark [4 ]
Ayers, John W. [1 ,3 ]
机构
[1] Univ Calif San Diego, Ctr Data Driven Hlth, Qualcomm Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA
[4] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA
关键词
SOLD;
D O I
10.1001/jamanetworkopen.2020.20977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Question Is the public using cannabidiol (CBD) to treat diagnosable conditions that have evidence-based therapies? Findings In this case series of 376 posts on a CBD forum on Reddit, most users reported taking CBD as a therapeutic for diagnosable conditions, including mental health, cardiological, dermatological, gastroenterological, ophthalmological, oral health, and sexual health conditions, many of which have other evidence-based treatment regimens. Meaning The findings suggest a need for interventions that address the use of CBD for unproven applications, including regulating therapeutic claims about CBD and redirecting patients to proven therapies in lieu of CBD. Importance Use of cannabidiol (CBD) has markedly increased in the past 5 years, concurrent with marketing claims that over-the-counter CBD can be used to treat almost any health condition. However, the reasons why individuals use CBD remain unclear. Objective To assess whether individuals are using CBD for diagnosable conditions that have evidence-based therapies. Design, Setting, and Participants This case series assessed claimed treatment applications reported by CBD users in public testimonials shared on the Reddit forum r/CBD. The r/CBD forum was selected because it includes a large, naturally occurring sample of 104917 registered individuals who publicly discuss their experiences using CBD. All r/CBD posts were obtained from January 1, 2014, through August 31, 2019. A random sample of posts was drawn (n = 3000) and filtered to include posts in which self-identified CBD users testified why they take CBD (n = 376). Exposures Self-reported use of CBD for medicinal purposes. Main Outcomes and Measures Cannabidiol testimonials were divided into 11 subcategories corresponding with the condition's medical subspecialty and 2 subcategories corresponding with wellness benefits. Posts were allowed to receive more than 1 label. Results Of the 376 posts labeled as testimonials, 90.0% (95% CI, 86.8%-92.8%) of testimonials claimed that CBD treated the individual's diagnosable conditions. Psychiatric conditions (eg, autism or depression) were the most frequently cited subcategory, mentioned in 63.9% (95% CI, 59.0%-69.1%) of testimonials, followed by orthopedic (26.4%; 95% CI, 21.8%-31.1%), sleep (14.6%; 95% CI, 11.3%-18.5%), and neurological (6.9%; 95% CI, 4.4%-9.6%) conditions. Testimonials also claimed that CBD treated gastroenterological conditions (3.9%; 95% CI, 1.9%-6.1%), as well as addiction, cardiological, dermatological, ophthalmological, oral health, and sexual health conditions (<2.0% each). By contrast, just 29.5% (95% CI, 24.8%-34.2%) of testimonies claimed any wellness benefit, with most citing mental wellness (eg, "quieting my mind") (29.5% [95% CI, 24.2%-34.4%]); 1.4% (95% CI, 0.3%-2.8%) claimed a physical wellness benefit (eg, "exercise performance"). Conclusions and Relevance The findings of this case series suggest a need for regulation of factors associated with CBD being used to treat diagnosable conditions, engagement of health care professionals with patients on their potential CBD use, and implementation of public health campaigns that encourage the public to seek treatment advice from health care professionals regarding evidence-based therapies. This case series assesses whether individuals are using cannabidiol (CBD) to treat diagnosable conditions with proven therapies.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [21] SELF-REPORTED ANTIDEPRESSANTS USE AND SPONTANEOUS ABORTION
    Chan, R. L.
    Funk, M. L. Jonsson
    Savitz, D. A.
    Hartmann, K. E.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S140 - S140
  • [22] Reporting bias and self-reported drug use
    Macleod, J
    Hickman, M
    Smith, GD
    ADDICTION, 2005, 100 (04) : 562 - 563
  • [23] The associations between self-reported depression, self-reported chronic inflammatory conditions and cognitive abilities in UK Biobank
    Lyall, Laura M.
    Cullen, Breda
    Lyall, Donald M.
    Leighton, Samuel P.
    Siebert, Stefan
    Smith, Daniel J.
    Cavanagh, Jonathan
    EUROPEAN PSYCHIATRY, 2019, 60 : 63 - 70
  • [24] Marijuana Use and Self-reported Quality of Eyesight
    Akano, Obinna F.
    OPTOMETRY AND VISION SCIENCE, 2017, 94 (05) : 630 - 633
  • [25] Self-reported use of strategies and mathematical modelling
    Schukajlow, Stanislaw
    Leiss, Dominik
    JOURNAL FUR MATHEMATIK-DIDAKTIK, 2011, 32 (01): : 53 - 77
  • [26] Reliability of self-reported household pesticide use
    Fortes, Cristina
    Mastroeni, Simona
    Boffetta, Paolo
    Salvatori, Valentina
    Melo, Nidia
    Bolli, Simone
    Pasquini, Paolo
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (05) : 404 - 406
  • [27] RELIABILITY OF SELF-REPORTED HOUSEHOLD PESTICIDES USE
    Fortes, C.
    Mastroeni, S.
    Boffetta, P.
    Salvatori, V.
    Melo, N.
    Bolli, S.
    Pasquini, P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S31 - S31
  • [28] Validation of self-reported cellular phone use
    Florence Samkange-Zeeb
    Gabriele Berg
    Maria Blettner
    Journal of Exposure Science & Environmental Epidemiology, 2004, 14 : 245 - 248
  • [29] The validity of self-reported marijuana and cocaine use
    Katz, CM
    Webb, VJ
    Gartin, PR
    Marshall, CE
    JOURNAL OF CRIMINAL JUSTICE, 1997, 25 (01) : 31 - 41
  • [30] Cessation of self-reported opioid use and impacts on co-occurring health conditions
    Scheidell, Joy D.
    Townsend, Tarlise
    Ban, Kaoon
    Caniglia, Ellen C.
    Charles, Dyanna
    Edelman, E. Jennifer
    Marshall, Brandon D. L.
    Gordon, Adam J.
    Justice, Amy C.
    Braithwaite, R. Scott
    Khan, Maria R.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 242